Summary Skin and nerve biopsies obtained from 18 multibacillary (MB) and 16 paucibacillary (PB) cases of leprosy who had been fu lly treated by the WHO regimen were assessed for bacterial load using different staining techniques. In addition skin and nerve homogenates of 10 MB cases were tested for 'persistor' My cobacterium leprae using immunosuppressed mice.
While significant amounts of integral bacilli and BCG cross-reactive antigen of M. leprae were detected both in skin and nerve tissues of all the MB cases (100%), 56% of skin and 62% of nerve biopsies of PB cases also showed the presence of BCG cross-reactive antigen.
Detection of , persist or' M. leprae in 2/ 10 skin biopsies (20%) and 3/10 nerve biopsies (30%) of MB cases was thought to be unexpectedly high after 2 years of MDT.
Although the peripheral nerves, and the Schwann cells in particular, are well recognized to be the seat of disease in leprosy, I decisions regarding diagnosis and therapy are based largely on skin manifestations and the presence or absence of bacilli within the skin lesions. This is chiefly because of the ease of investigation and also because skin lesions do provide a good indication of the activity of the disease process. However, it has been demonstrated in histopathological studies that in the same patient, nerves generally show lesions which are more advanced and also harbour bacilli exhibiting solid fo rms which indicate a higher degree of viability.2,3 This is believed to be because nerves, being immunologically protected, are favoured sites for bacillary survival and multiplication,4,5 It is possible that after prolonged chemotherapy, while skin lesions may not have viable bacilli, some viable bacilli may persist within the nerves and may cause a relapse at a later stage after therapy has stopped. THELEP trials with MDT at Bamako and Chingleput showed the presence of persistor M. leprae in 9% of cases.6
The present study was undertaken in order to determine and compare the bacterial load as well as the viability within the peripheral nerves and the skin of leprosy patients who had been treated with the WHO recommended multidrug therapy.
Patients and method
A total of 18 muItibacillary cases (BL-LL) treated for a minimum of 2 years and 16 paucibacillary cases (BT -TT)7 treated for a minimum of 6 months with the WHO recommended multidrug regime8 were studied for bacterial load in the skin and nerve using different staining techniques. Additionally skin and nerve biopsies from 10 of the multi bacillary cases were studied for bacterial viability using the mouse fo otpad technique.
Where possible, skin biopsies of all the cases were taken from lesions that appeared most active, but in the absence of any active lesions, the choice of biopsy in lepromatous patients was either earlobe. In tuberculoid patients with healed lesions, the biopsy was taken from a clinically inactive lesion. The selection of the peripheral nerve for biopsy was based on the amount of clinical and electrophysiological involvement. An involved sural nerve was biopsied in all except 1 of the lepromatous patients, the biopsy in the tuberculoid patients varied according to the site of involvement and included the sural (6), NO, not done; semiquantative grades: BI =0 to 6 + ( Ridley OS 1964 , 1985 ; AntiBCG =O to 4 + _ the cutaneous branch of the radial (7), the cutaneous branch of the ulnar (I), the lateral thoracic (1) and the superficial peroneal (1).
Determination of the bacterial load
The fo llowing methods were employed for the determination of the bacterial load:
a Multiple slit-skin smears were obtained from all the patients before biopsy. Smears stained with Fite-Farraco were scored for their bacterial index (BI) using Ridley's scale.9 b Paraffin sections of skin and nerve biopsies were stained with Trichrome modified Fite Farraco (TRIFF) and the bacterial index was determined on tissue sections using Ridley's method.1o c Paraffin sections of skin and nerve tissues were also stained with anti-BeG antibody (from DAKO) for cross-reactive Mycobacterial antigen using the peroxidase antiperoxidase (PAP) technique. d Araldite embedded ultrathin transverse sections of the nerve were scanned for the presence of osmiophilic bacilli using electron microscopy (EM). We determined the bacterial index (BI) at EM level for a given cross-section on the fo llowing grounds.
I + = 1 or 2 cells carrying few bacilli ( < 10); 2 + = few cells carrying single to small clusters of bacilli (> 10 to < 100); 3 + = several cells carrying clusters of bacilli (> 100), and so on.
All these are well standardized, routinely used techniques in our laboratory. 
Determination of bacterial viability
Skin and nerve homogenates from 10 of the above-treated multi bacillary cases only, were studied for bacterial viability. Skin and nerve homogenates were prepared immediately after biopsy using sterile measures. The bacterial load per gram weight of skin and nerve tissues was determined using WHO guidelines and 0·03 ml of the homogenate containing not more than 105 bacteria were injected into both hind fo otpads of Swiss white mice thymectomized and irradiated with 5 graded doses of200 rad each of , X' irradiation at bi weekly intervals. I I A minimum of 8 mice were used for each inoculum. Footpad harvests were done at the end of 12 months.
Summary of results

BACTERIAL LOAD USING DIFFERENT STAINING TECHNIQUES
Multibacillary cases (M B) : (Table 1) Of the 18 MB cases studied, 6 scored negative in all the smears and the remaining 12 cases (66·6%) ( Table 3) were positive with bacterial indices ranging from I + to 5 + in the skin.
On paraffin sections stained with TRIFF, 4 of the skin biopsies scored negative for acid-fast bacilli (AFB), whereas 1 skih biopsy showed negative anti-BeG staining. In the case of nerve biopsies, 8 out of 17 did not show AFB in TRIFF stained longitudinal and transverse (LS & TS) sections, whereas all the nerves (both LS & TS) were positive for anti-BeG.
In spite of the small sample size used for electron microscopy, all the nerve biopsies showed the presence of osmiophilic bacilli in the endoneurium (Tables 1 and 3 ).
Paucibacillary cases (P B) : (Table 2) None of the treated PB cases (BT -TT) showed any bacilli in the smear, whereas 2 of the skin biopsies stained with TRIFF showed a few bacilli in the deep dermal nerves. However 9 of the skin biopsies (56,2%) showed significant BeG positivity in the epithelioid cells.
Of the nerve biopsies, 2 showed bacilli in TRIFF, whereas 10 out of 16 nerve biopsies (62, 5% Table 3) showed BeG positivity mainly in the Schwann cells. It was interesting to note that 5 of the nerve biopsies showed the presence of osmiophilic bacilli mostly in Schwann cells at the ultrastructural level. BACTERIAL VIABILITY USING T200 x 5R MICE Both skin and nerve homogenates of 2 patients and only nerve homogenate of I patient showed over lO-fold growth in the mouse fo otpad (Table 4) . One of the patients, where both skin and nerve homogenates showed > 10 fold growth had completed 32 doses of MDT and he was on treatment during biopsy. The bacterial index of his smears ranged fr om 2 + to 4 +. The other 2 patients had completed 24 doses of MDT, were smear negative and were off treatment fo r 2 months before biopsy.
In 5 out of 10 nerve homogenates (50%) and 2 out of 10 skin homogenates (20%) there was more than a 5-fold increase in fo otpad count which requires reconfirming to satisfy the WHO protocol.
Even though the bacterial load per gram weight of skin tissue was higher than that of nerve tissue (Table 6 ) the number of fo otpads showing over a lO-fold gro�·th with nerve homogenate was twice more (10/52, i.e. 19'2%) than that of the skin homogenate (4/60, i.e. 6'7%) suggesting the presence of a higher number of viable organisms in the nerve (Table 5) . By applying the X2 test for goodness of fit the difference was found to be of borderline significance of p < 0·05. A semiquantitative analysis of the results reveal that detection of the BeG cross-reactive antigen using the PAP technique is far superior and more sensitive than the detection of acid-fast organisms using TRIFF staining in tissue sections, which in turn is superior to the smear technique. This is in accordance with the findings of Mshana et a/. 1 2 Interestingly, detection of osmiophilic bacilli using an osmium-fixed araldite embedded ultrathin section is similar to the BeG cross-reactive antigen detection system in spite of the small sample size.
It is noteworthy that among the paucibacillary cases there is no concordance between BeG positivity of skin and nerve biopsies even though both biopsies were obtained simultaneously fr om the most active site of involvement.
The continued presence of both integral and BeG cross-reactive antigen of M. leprae in skin and nerve biopsies of MB cases after completion of treatment is not surprising since it is expected that the dead bacteria and its residues may take longer to clear from intracellular locations. However, 56% of skin and 62% of nerve biopsies of PB cases showed a persistence of bacterial antigen which is surprising. It is assumed that the initial load of bacteria in these cases is not more than 106• This low load combined with 2 highly potent bactericidal drugs taken for a period of7-18 months in some cases (Table 2) clearly raises questions regarding the ability of these individuals to mount a better immune response that facilitates fa ster bacterial clearance. It is worth mentioning that 4 of the patients (Nos 4, 7, 9 and 13, Table 2 ) who were showing a significant amount of antigen in both skin and nerve had not only taken 7-18 months of treatment but the biopsies under study were obtained 6-1 1 months after stopping the treatment. This is in contrast to the expectations that the clearance of bacterial products would be fa ster after the withdrawal of antileprosy drugs which are partially immunosuppressive.13,14 Alternative strategies need to be worked out to neutralize these antigens.
The presence of these antigens in any fo rm of leprosy (PB or MB) can pose a potential danger in bringing about reversal reactions. The study of how and where these antigens are located in relation to the activity of the lesion might have an important bearing on any impending reaction, and this is also being studied and will be reported elsewhere.
Preliminary data in the second part of the study reveal that 2 out of lO skin biopsies and 3 out of lO nerve biopsies harboured significant numbers of viable bacteria, which is unexpectedly high. Our results also reveal that the viable number of bacteria in the nerve is twice that in the skin tissue. This observation calls for a fresh look at the efficacy of MDT which is the major tool in leprosy eradication programmes. We are inclined to believe that for cessation of therapy, the clinical evidence of disease inactivity and slit-skin smear negativity should be viewed with caution. Indeed a larger investigation including MB as well as PB cases needs to be undertaken, keeping in mind the possibility of multidrug resistance and bioavailability of anti leprosy drugs. La detection de My cobacterium /eprae 'persisteur' dans 2/10 biopsies de peau (20% ) et 3/ 10 biopsies du nerf (30% ) chez les cas MB semble plus elevee que prevu apres 2 annees de traitement multidrogue.
La persistencia del My cobacterium /eprae en el nervio periferico com parada a la piel de los leprosos tratados con multi-drogas v P SHETTY, K SUCHITRA, M W UPLEKAR Y N H ANTIA Resumen Biopsias de la piel y de nervios obtenidas de ISleprosos multibacilares (MB) y 16 paucibacilares (PB) que habian recibido un tratamiento completo con el regimen de la OMS, fueron evaluadas para carga bacteriana utilizando diferentes tecnicas de coloracion. Ademas, productos homogenizados de piel y nervios en 10 casos MB fueron probados para My cobacterium /ep rae 'persistor' mediante ratones immunosuprimidos.
Aunque se detectaron cantidades significativas de bacilos integros y antigeno BeG de reactividad cruzada de M. /eprae tanto en tejidos de pie! como de nervios, en todos los casos MB (100%), 56% de las biopsias de pie! y 62% de las de nervios en los casos PB tam bien mostraron la presencia de antigeno BeG de reactividad cruzada.
Se cree que la deteccion de M. /eprae 'persistor' en 2/ 10 de las biopsias de la piel (20%) y en 3/10 biopsias de nervi os (30%) en los casos MB fue inesperadamente alta despues de 2 aiios de MDT.
